Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 52
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 35 of 54)
- Relevance
  Sort by

Smallpox Treatment Market 2024-2028

 Report
November 2024
168 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Cytomegalovirus (CMV) Therapeutics Market 2024-2028

 Report
October 2024
144 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Anemia and Other Blood Disorder Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032

 Report
February 2022
308 Pages
Global

From

€8340EUR$9,500USD£7,255GBP

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€3292EUR$3,750USD£2,864GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hypophosphatasia Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Cancer Antibody Drug Conjugates - Global Strategic Business Report

 Report
September 2025
482 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Chemotherapy Treatment - Global Strategic Business Report

 Report
September 2025
188 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Blastic Plasmacytoid Dendritic Cell Neoplasm - Global Strategic Business Report

 Report
September 2025
285 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Personalized Cancer Medicines - Global Strategic Business Report

 Report
September 2025
267 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Cancer Biological Therapy - Global Strategic Business Report

 Report
September 2025
211 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Blood Cancer Therapeutics - Global Strategic Business Report

 Report
September 2025
291 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Investor Series: Opportunities in the Cell and Gene Therapy Market

 Report
April 2022
121 Pages
Global

From

€1667EUR$1,899USD£1,450GBP

Company Snapshots: US Biotechnology

 Newsletter
September 2025
35 Pages
United States

From

€263EUR$300USD£229GBP

PD-1 and PD-L1 Inhibitors Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Antibody Drug Conjugates (ADC) - Global Strategic Business Report

 Report
September 2025
193 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology (Type-cleavable, Non-cleavable), By Product, By Target, By Region, And Segment Forecasts, 2024 - 2030

 Report
April 2024
125 Pages
Global

From

€5224EUR$5,950USD£4,544GBP

Sickle Cell Disease Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Myelodysplastic Syndrome (MDS) Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
114 Pages
Global

From

€4170EUR$4,750USD£3,627GBP

Anal Fissure Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

1,070 Results (Page 35 of 54)
- 1
- 33
- 34
- 35
- 36
- 37

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.